Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Using Integrated Bite Case Management to estimate the burden of rabies and evaluate surveillance in Oriental Mindoro, Philippines.
Swedberg C, Miranda MEG, Bautista C, Anderson D, Basa-Tulio M, Chng NR, Cruz VDD, Kundegorski M, Maestro J, Manalo D, Maniszewska K, Manzanilla DR, Mazeri S, Mellanby RJ, Pablo-Abarquez S, Quiambao B, Telmo SVM, Trotter C, Yuson M, Hampson K. Swedberg C, et al. Among authors: quiambao b. One Health Implement Res. 2023 Aug 31;3:77-96. doi: 10.20517/ohir.2023.02. One Health Implement Res. 2023. PMID: 37841079 Free PMC article.
Molecular Analysis of Rabies Virus Using RNA Extracted from Used Lateral Flow Devices.
Mauhay JD, Saito N, Kimitsuki K, Mananggit MR, Cruz JL, Lagayan MG, Garcia AM, Lacanilao PM, Yamada K, Saito-Obata M, Manalo DL, Demetria CS, Quiambao BP, Nishizono A. Mauhay JD, et al. Among authors: quiambao bp. J Clin Microbiol. 2023 Mar 23;61(3):e0154322. doi: 10.1128/jcm.01543-22. Epub 2023 Feb 22. J Clin Microbiol. 2023. PMID: 36840574 Free PMC article.
A phase 2b, Randomized, double blinded comparison of the safety and efficacy of the monoclonal antibody mixture SYN023 and human rabies immune globulin in patients exposed to rabies.
Quiambao BP, Payumo RA, Roa C, Borja-Tabora CF, Emmeline Montellano M, Reyes MRL, Zoleta-De Jesus L, Capeding MR, Solimen DP, Barez MY, Reid C, Chuang A, Tsao E, McClain JB. Quiambao BP, et al. Vaccine. 2024 Sep 17;42(22):126018. doi: 10.1016/j.vaccine.2024.05.066. Epub 2024 Jun 4. Vaccine. 2024. PMID: 38834432 Clinical Trial.
Implications of the antiviral drug favipiravir on rabies immunoglobulin for post-exposure prophylaxis of rabies in mice model with category III-like exposures.
Kimitsuki K, Khan S, Kaimori R, Yahiro T, Saito N, Yamada K, Nakajima N, Komeno T, Furuta Y, Quiambao BP, Virojanapirom P, Hemachudha T, Nishizono A. Kimitsuki K, et al. Among authors: quiambao bp. Antiviral Res. 2023 Jan;209:105489. doi: 10.1016/j.antiviral.2022.105489. Epub 2022 Dec 10. Antiviral Res. 2023. PMID: 36513207 Free article.
One-week intramuscular or intradermal pre-exposure prophylaxis with human diploid cell vaccine or Vero cell rabies vaccine, followed by simulated post-exposure prophylaxis at one year: A phase III, open-label, randomized, controlled trial to assess immunogenicity and safety.
Quiambao BP, Lim JG, Bosch Castells V, Augard C, Petit C, Bravo C, Delore V, Houillon G. Quiambao BP, et al. Vaccine. 2022 Aug 26;40(36):5347-5355. doi: 10.1016/j.vaccine.2022.07.037. Epub 2022 Aug 3. Vaccine. 2022. PMID: 35933278 Free article. Clinical Trial.
60 results